Works matching Amyotrophic lateral sclerosis treatment


Results: 886
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2018, v. 19, n. 3/4, p. 259, doi. 10.1080/21678421.2018.1426770
    By:
    • Andrews, Jinsy A.;
    • Cudkowicz, Merit E.;
    • Hardiman, Orla;
    • Meng, Lisa;
    • Bian, Amy;
    • Lee, Jacqueline;
    • Wolff, Andrew A.;
    • Malik, Fady I.;
    • Shefner, Jeremy M.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    A fair innings for NICE?

    Published in:
    2002
    By:
    • Freemantle, N.;
    • Bloor, K.;
    • Eastaugh, J.;
    • Freemantle, Nick;
    • Bloor, Karen;
    • Eastaugh, Joanne
    Publication type:
    journal article
    27
    28

    Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial.

    Published in:
    Brain Communications, 2024, v. 6, n. 5, p. 1, doi. 10.1093/braincomms/fcae304
    By:
    • Gianferrari, Giulia;
    • Costantini, Riccardo Cuoghi;
    • Crippa, Valeria;
    • Carra, Serena;
    • Bonetto, Valentina;
    • Pansarasa, Orietta;
    • Cereda, Cristina;
    • Zucchi, Elisabetta;
    • Martinelli, Ilaria;
    • Simonini, Cecilia;
    • Vicini, Roberto;
    • Fini, Nicola;
    • Trojsi, Francesca;
    • Passaniti, Carla;
    • Ticozzi, Nicola;
    • Doretti, Alberto;
    • Diamanti, Luca;
    • Fiamingo, Giuseppe;
    • Conte, Amelia;
    • Bella, Eleonora Dalla
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    38
    39
    40
    42
    43

    Antioxidant Drug Approved for ALS.

    Published in:
    JAMA: Journal of the American Medical Association, 2017, v. 317, n. 23, p. 2363, doi. 10.1001/jama.2017.6974
    By:
    • Voelker, Rebecca
    Publication type:
    Article
    44

    JAMA NETWORK ABSTRACTS.

    Published in:
    JAMA: Journal of the American Medical Association, 2013, v. 309, n. 22, p. 2310
    Publication type:
    Article
    45
    46

    Case & Comment.

    Published in:
    Patient Care (Print), 2002, v. 36, n. 4, p. 47
    By:
    • Pennachio, Dorothy L.
    Publication type:
    Article
    47

    In this issue.

    Published in:
    Molecular Therapy, 2013, v. 21, n. 12, p. 2134, doi. 10.1038/mt.2013.253
    Publication type:
    Article
    48
    49